Investment Summary |
|
|---|---|
| Date | 2021-01-19 |
| Target | SPINS |
| Sector | Information Technology |
| Investor(s) |
General Atlantic
Warburg Pincus |
| Deal Type | Growth Capital |
| Advisor(s) | Jefferies (Financial) Reed Smith (Legal) |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1980 |
| PE ASSETS | 105.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
General Atlantic is a large private equity firm that invests globally in growth-oriented public and private companies. Broad areas of interest include financial services, media and consumer, healthcare, enterprise solutions, communications and electronics, and energy. General Atlantic looks to invest $40 to $400 million in transactions that support growth, expansions, buy-outs, consolidations and build-ups. General Atlantic seeks to make 8 to 12 investments per year with an investment horizon of five to ten years. The Firm's geographic coverage spans North America; Europe; Asia/Pacific; and India. General Atlantic was formed in 1980 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 266 of 364 |
| Sector: Information Technology M&A | 30 of 45 |
| Type: Growth Capital M&A Deals | 110 of 140 |
| State: Illinois M&A | 9 of 11 |
| Country: United States M&A | 125 of 175 |
| Year: 2021 M&A | 2 of 46 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-01-05 |
Chronosphere
New York, New York, United States Chronosphere is a cloud-native data monitoring platform built on M3. Chronosphere was founded in 2019 and is based in New York, New York. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-02-04 |
Immunocore
Abingdon, United Kingdom Immunocore is a late-stage biotechnology company focused on the development of a novel class of TCR bispecific immunotherapies called ImmTAX, Immune mobilizing monoclonal TCRs Against X disease, designed to treat a broad range of diseases, including cancer, infectious, and autoimmune. Immunocore was founded in 1999 and is based in Abingdon, England. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1966 |
| PE ASSETS | 83.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Warburg Pincus is a mega-sized, global private equity firm focused on investment opportunities across North America, Asia, and Europe. Warburg will consider investing at various company stages, from early-stage opportunities to distressed situations. Warburg Pincus is organized by industry groups. Verticals include financial services, healthcare, technology, media & telecommunications, energy, consumer & industrial, and real estate. Within financial services, Warburg will consider asset/wealth managers, banks, exchanges, financial technology, insurance, transaction processing, private banking, and specialty/consumer finance. Within healthcare, specific areas of interest include medical devices, healthcare services, and biotech/pharmaceuticals. Within technology/media/communications, Warburg targets software, media/internet/information, financial technology, telecom, business services, and systems/semiconductors. Within energy, specific areas of interest include oil/gas exploration, power generation/transmission, and alternative energy. Warburg Pincus raised its first fund in 1966 and is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 437 of 492 |
| Sector: Information Technology M&A | 35 of 44 |
| Type: Growth Capital M&A Deals | 144 of 159 |
| State: Illinois M&A | 6 of 8 |
| Country: United States M&A | 212 of 241 |
| Year: 2021 M&A | 4 of 18 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-01-08 |
Abbisko Therapeutics
Shanghai, China Abbisko Therapeutics is an oncology focused biopharmaceutical company dedicated to the discovery and development of innovative medicines for unmet medical needs in China and around the world. Abbisko Therapeutics was founded in 2016 and is based in Shanghai, China. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-02-16 |
Hygiena
Camarillo, California, United States Hygiena LLC is a microbiology and life science company that serves industrial food processors, healthcare institutions, life science researchers and the general public. The Company manufactures and sells a broad range of rapid hygiene monitoring systems, environmental collection systems and rapid dilution devices. Its products are distributed in over 50 countries worldwide. Hygiena was formed in 2000 and is headquartered in the United States in Camarillo, California with a satellite office in the United Kingdom. |
Sell | - |
